HKUMed Unveils Broader Potential of Fatty Liver Medication in Liver Cancer Prevention and Treatment
A groundbreaking study from researchers at the University of Hong Kong’s School of Clinical Medicine reveals that Resmetirom, an FDA-approved ...
A groundbreaking study from researchers at the University of Hong Kong’s School of Clinical Medicine reveals that Resmetirom, an FDA-approved ...
Recent advances in targeting p21-activated kinase 4 (PAK4) have unveiled transformative potential for therapeutic intervention, particularly in the realms of ...
In a groundbreaking study that could transform our understanding of metabolic liver diseases, researchers have unveiled a novel biochemical modification ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine